Skip to main content
Equibles

Candriam S.C.A.

Position in BSX — Boston Scientific Corp

CIK 1537014 STRASSEN, N4
Back to BSX Full portfolio

Position in BSX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,684,259
-$63,472,418 QoQ
Shares Held
367,485
-70.9% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#258
of 1,477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $207,022,064 across 9 Medical Devices names. BSX ranks #6 (7.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EW
Edwards Lifesciences Corp
 663,784 $60,045,900
2 SYK
Stryker Corp
 161,744 $50,923,480
3 BRKR
Bruker Corp
 411,700 $24,776,106
4 PODD
Insulet Corp
 151,100 $23,004,975
5 ABT
Abbott Laboratories
 211,167 $19,161,293
6 BSX
Boston Scientific Corp
This page 		367,485 $15,684,259
7 DXCM
Dexcom Inc
 160,272 $10,794,319
8 GEHC
GE HealthCare Technologies Inc.
 21,571 $1,380,759

All Filings in BSX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,684,259 367,485
2026-03-31 $79,156,677 1,261,461
2025-12-31 $107,730,053 1,129,838
2025-09-30 $121,790,593 1,247,471
2025-06-30 $89,797,445 836,025
2025-03-31 $35,308 350
2025-03-31 $41,846,234 414,812
2024-12-31 $34,991,824 391,758
2024-09-30 $39,797,877 474,915
2024-06-30 $33,633,424 436,741
2024-03-31 $28,972,023 423,011
2023-12-31 $28,182,317 487,499
2023-09-30 $23,455,396 444,231
2023-06-30 $18,336,726 339,004
2023-03-31 $20,648,631 412,725
2022-12-31 $18,317,275 395,878
2022-09-30 $17,015,483 439,336
2022-06-30 $8,281,953 222,215
2022-03-31 $3,359,573 75,854
2021-12-31 $3,159,280 74,371
2021-09-30 $3,609,700 83,192
2021-06-30 $3,554,082 83,117
2021-03-31 $3,336,770 86,333
2020-12-31 $3,103,671 86,333
2020-09-30 $2,873,392 75,200
2020-06-30 $2,853,284 81,267
2020-03-31 $3,313,674 101,553